about
sameAs
Release of U18 snoRNA from its host intron requires interaction of Nop1p with the Rnt1p endonuclease.Rrp15p, a novel component of pre-ribosomal particles required for 60S ribosome subunit maturation.Nob1p is required for cleavage of the 3' end of 18S rRNAGene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223MicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneMaking ribosomes.PIN domain of Nob1p is required for D-site cleavage in 20S pre-rRNAPurified box C/D snoRNPs are able to reproduce site-specific 2'-O-methylation of target RNA in vitroYeast Rrp14p is required for ribosomal subunit synthesis and for correct positioning of the mitotic spindle during mitosis.Cic1p/Nsa3p is required for synthesis and nuclear export of 60S ribosomal subunitsSsf1p prevents premature processing of an early pre-60S ribosomal particle.The cotranscriptional assembly of snoRNPs controls the biosynthesis of H/ACA snoRNAs in Saccharomyces cerevisiae.Naf1 p is a box H/ACA snoRNP assembly factorMicroarray detection of novel nuclear RNA substrates for the exosome.A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesisCirc-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis.CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemiaFunctional analysis of yeast snoRNA and snRNA 3'-end formation mediated by uncoupling of cleavage and polyadenylation.Long non-coding RNAs: new players in cell differentiation and development.The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation.Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells.A feedforward regulatory loop between HuR and the long noncoding RNA linc-MD1 controls early phases of myogenesis.Role of microRNAs in hematological malignancies.Noncoding RNAs in Acute Myeloid Leukemia: From Key Regulators to Clinical PlayersThe role of long noncoding RNAs in the epigenetic control of gene expression.Critical Role of c-Myc in Acute Myeloid Leukemia Involving Direct Regulation of miR-26a and Histone Methyltransferase EZH2.Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia.Non-coding RNAs in muscle differentiation and musculoskeletal disease.The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.Role of microRNAs in myeloid differentiation.Isolation and characterization of CD146+ multipotent mesenchymal stromal cells.Heterochromatin protein 1 (HP1a) positively regulates euchromatic gene expression through RNA transcript association and interaction with hnRNPs in DrosophilaThe microRNA-26a target E2F7 sustains cell proliferation and inhibits monocytic differentiation of acute myeloid leukemia cells.Fibrillarin binds directly and specifically to U16 box C/D snoRNA.A new molecular network comprising PU.1, interferon regulatory factor proteins and miR-342 stimulates ATRA-mediated granulocytic differentiation of acute promyelocytic leukemia cells.NFI-A directs the fate of hematopoietic progenitors to the erythroid or granulocytic lineage and controls beta-globin and G-CSF receptor expression.Effect of miR-204&211 and RUNX2 control on the fate of human mesenchymal stromal cells.Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer.N6-Methyladenosine Role in Acute Myeloid LeukaemiaArgonaute 2 drives miR-145-5p-dependent gene expression program in breast cancer cells
P50
Q24536038-4D78F6F7-B146-4777-9885-03F73D6BC27AQ24537366-146BC7CB-E5CA-4B2A-9D1F-971212FFD8FEQ24554334-4F17E687-B855-4AFD-8DF7-B227797D52F7Q24624017-018C6230-4594-422F-B617-A7AEE2FECBA2Q27013740-35C59ED6-FB6A-4C10-ADE7-E82DB273A63BQ27930690-FED4022F-9217-4B5B-BA6E-C9564B969E34Q27933019-9DEE6848-2960-46AC-AC66-9E90EB2AD424Q27934016-600E51D8-6C23-435F-9D8D-83690C339239Q27934121-536163CE-6759-46AC-9DC3-B175358B49E3Q27934976-708B3E7A-CBAB-49CA-B085-5E535E8783CEQ27935091-566BD550-4846-4132-A2C9-F00F42FA8D26Q27937034-831F90CC-B75D-4330-8654-9D2D2AC29EB8Q27937608-50AA94BD-C56E-4423-8427-0BD00F96FB54Q27938447-FB6E5660-CC3D-4B25-B1D8-E55F62C11A6AQ29619201-F44DA83D-5BAC-4F9E-A8BF-74D620212434Q29871124-E67CA5B3-414D-48FC-B230-C3C54E04A87BQ34256021-1AFFFE1E-148D-40B0-8BF1-B2A7D7A4386AQ34302582-64DF399F-5D4F-465F-8BAD-B86A2B18B4A0Q34389273-E4141680-BDD5-41BD-92E0-63B2E42E9EFEQ36288893-38BAEB99-763A-4323-86E6-A31953AD7FE0Q37357102-55201733-B2DC-4E64-BD17-4AE960935E52Q37572646-3014BDDE-A801-464A-A465-9B6BA31F18B8Q37810078-8C65E94E-D432-4453-930B-8934DFA7B420Q38166375-CCA03B8D-8454-4953-925C-9D1D105C7322Q38184514-E117EAA4-0324-40C6-8274-2A632C12132EQ38259629-554634A9-E40F-4982-923A-10BC42093149Q38450930-2879C271-F2FF-486D-A06E-05CAF5F192CBQ38850158-8A2512C5-F3DA-4758-8E70-9D24E12A4375Q39496128-89ABE7DD-86B0-4589-AA7D-997F40BA1CF9Q39914112-734E1578-846E-405C-BBF0-BCC26151633FQ39978569-415CFE2D-7AE0-4BCC-8E12-40B1CC94EC06Q41951844-3DE8F5B7-AAF4-434A-B124-F35FE81DD0C2Q42063012-1B11123C-7381-4B18-8914-C8E76A746A15Q42737969-9F076303-2DD6-4010-B4B8-13D7FB120D7DQ43609668-32935AB2-E494-4B34-85D9-A68C45088F48Q45960681-56231C98-CE28-408A-9B31-C36141CBBCFEQ47281255-56E29BA4-E90D-4D5B-85E8-109C4E31C031Q50002288-0D7E1535-969B-495D-BA06-90757CBF231CQ58792484-39E8D42A-8CF9-4D88-9157-59281B454416Q60915962-129822FC-FBBB-43D1-86DC-1EC5EEB9645B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandro Fatica
@ast
Alessandro Fatica
@en
Alessandro Fatica
@es
Alessandro Fatica
@nl
Alessandro Fatica
@pt
Alessandro Fatica
@sl
type
label
Alessandro Fatica
@ast
Alessandro Fatica
@en
Alessandro Fatica
@es
Alessandro Fatica
@nl
Alessandro Fatica
@pt
Alessandro Fatica
@sl
prefLabel
Alessandro Fatica
@ast
Alessandro Fatica
@en
Alessandro Fatica
@es
Alessandro Fatica
@nl
Alessandro Fatica
@pt
Alessandro Fatica
@sl
P106
P1153
6602144826
P21
P31
P496
0000-0002-0743-7905